---
title: "Pulse Biosciences grants inducement stock options for 9,000 shares at USD 25.89 each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292810638.md"
description: "Pulse Biosciences granted inducement stock options for 9,000 shares to three new employees on July 13, 2026. The options carry an exercise price of $25.89 per share, set at the closing price on the grant date. The awards vest over four years, with 25% vesting annually, contingent upon continued employment."
datetime: "2026-07-15T20:06:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292810638.md)
  - [en](https://longbridge.com/en/news/292810638.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292810638.md)
generator: "portal-rs"
---

# Pulse Biosciences grants inducement stock options for 9,000 shares at USD 25.89 each

-   Pulse Biosciences granted inducement stock options to three new employees covering 9,000 shares, issued July 13, 2026. \* Options carry a $25.89 exercise price, set at the stock’s July 13, 2026 close. \* Awards vest over four years, with 25% vesting each year, subject to continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607151605BIZWIRE\_USPR\_\_\_\_\_20260715\_BW674831) on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PLSE.US](https://longbridge.com/en/quote/PLSE.US.md)

## Related News & Research

- [Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform](https://longbridge.com/en/news/296024769.md)
- [vTv Therapeutics grants 2,500 inducement stock options priced at $31.48 per share](https://longbridge.com/en/news/296394653.md)
- [Atrium Therapeutics awards new hire stock options for 11,000 shares at $13.48 each](https://longbridge.com/en/news/296541914.md)
- [Protagonist Therapeutics grants inducement equity awards for 7,175 shares to new hires at USD 155.1 strike price](https://longbridge.com/en/news/296264888.md)
- [Xylem sets quarterly distribution at R$ 0.75 per unit for 3Q 2026](https://longbridge.com/en/news/296117630.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**